[go: up one dir, main page]

DK0513000T3 - Kvalitetsforbedring af IMR-billeder af knogler og lignende væv ved hjælp af paramagnetiske kationkomplekser og polyphosphonatligander - Google Patents

Kvalitetsforbedring af IMR-billeder af knogler og lignende væv ved hjælp af paramagnetiske kationkomplekser og polyphosphonatligander

Info

Publication number
DK0513000T3
DK0513000T3 DK90917189.4T DK90917189T DK0513000T3 DK 0513000 T3 DK0513000 T3 DK 0513000T3 DK 90917189 T DK90917189 T DK 90917189T DK 0513000 T3 DK0513000 T3 DK 0513000T3
Authority
DK
Denmark
Prior art keywords
imr
bones
images
quality improvement
polyphosphonate
Prior art date
Application number
DK90917189.4T
Other languages
English (en)
Inventor
Harry S Winchell
Joseph Y Klein
Elliot D Simhon
Rosa L Cyjon
Ofer Klein
Haim Zaklad
Original Assignee
Concat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concat Ltd filed Critical Concat Ltd
Application granted granted Critical
Publication of DK0513000T3 publication Critical patent/DK0513000T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Veterinary Medicine (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90917189.4T 1989-11-27 1990-10-17 Kvalitetsforbedring af IMR-billeder af knogler og lignende væv ved hjælp af paramagnetiske kationkomplekser og polyphosphonatligander DK0513000T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44114489A 1989-11-27 1989-11-27

Publications (1)

Publication Number Publication Date
DK0513000T3 true DK0513000T3 (da) 1996-12-30

Family

ID=23751720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917189.4T DK0513000T3 (da) 1989-11-27 1990-10-17 Kvalitetsforbedring af IMR-billeder af knogler og lignende væv ved hjælp af paramagnetiske kationkomplekser og polyphosphonatligander

Country Status (10)

Country Link
EP (1) EP0513000B1 (da)
JP (1) JP2593963B2 (da)
AT (1) ATE140869T1 (da)
AU (1) AU649001B2 (da)
CA (1) CA2069638C (da)
DE (1) DE69028001T2 (da)
DK (1) DK0513000T3 (da)
ES (1) ES2091251T3 (da)
GR (1) GR3020861T3 (da)
WO (1) WO1991007911A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
AU3324193A (en) * 1991-12-10 1993-07-19 Dow Chemical Company, The Oral compositions for inhibiting plaque and calculus formation
US5555884A (en) * 1992-12-16 1996-09-17 Kabushiki Kaisha Egawa Measuring method by using resonance of a resonance medium
US5714604A (en) * 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US5409689A (en) * 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
EP1637524A1 (en) * 2004-09-20 2006-03-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 10-substituted 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane derivative for use as contrast agents
JP5690733B2 (ja) * 2009-08-20 2015-03-25 富士フイルムＲｉファーマ株式会社 ビスホスホン酸誘導体及びその放射性金属核種標識体
JP7582942B2 (ja) * 2018-11-16 2024-11-13 ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク アニオン性ペンダントおよび補助基を含む、鉄（ｉｉｉ）ｍｒｉ造影剤として使用するための化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515766A (en) * 1980-06-23 1985-05-07 The Massachusetts General Hospital Labeled phosphonic acid compositions for investigations of in vivo deposits of calcium
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3237573A1 (de) * 1982-10-09 1984-04-12 Hoechst Ag, 6230 Frankfurt Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
GB8701054D0 (en) * 1987-01-16 1987-02-18 Amersham Int Plc Contrast agent for nmr scanning
GB8903023D0 (en) * 1989-02-10 1989-03-30 Parker David Chemical compounds
GB8914543D0 (en) * 1989-06-23 1989-08-09 Parker David Chemical compounds
HU211735B (en) * 1990-06-18 1995-12-28 Dow Chemical Co Method for obtaining macrocyclic amino-phosphonic acid complexes

Also Published As

Publication number Publication date
ES2091251T3 (es) 1996-11-01
EP0513000B1 (en) 1996-07-31
DE69028001D1 (de) 1996-09-05
EP0513000A4 (en) 1992-09-01
EP0513000A1 (en) 1992-11-19
DE69028001T2 (de) 1996-12-19
ATE140869T1 (de) 1996-08-15
CA2069638C (en) 1999-02-09
GR3020861T3 (en) 1996-11-30
WO1991007911A1 (en) 1991-06-13
JP2593963B2 (ja) 1997-03-26
AU649001B2 (en) 1994-05-12
JPH05504127A (ja) 1993-07-01
CA2069638A1 (en) 1991-05-28
AU6732290A (en) 1991-06-26

Similar Documents

Publication Publication Date Title
DK0513000T3 (da) Kvalitetsforbedring af IMR-billeder af knogler og lignende væv ved hjælp af paramagnetiske kationkomplekser og polyphosphonatligander
DK0836380T3 (da) FGF9 som en specifik ligand for FGFR3
EP1100535A4 (en) Targeting pharmaceutical agents to injured tissues
FI922151A0 (fi) Metall-peptidkompositioner och metoder foer stimulering av haortillvaext.
ATE347910T1 (de) Zusammensetzungen zur behandlung von ischamischem gewebe
DE3751788D1 (de) Polysubstituierte Diethylentriamin Chelate zur Bildung einer Metall-Chelat-Protein Konjugierung
DK280789D0 (da) Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse
PT907379E (pt) Agentes de contraste bioactivados para imagiologia de diagnostico
ATE212846T1 (de) Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund
ATE131073T1 (de) Konjugate zur knochenbilddarstellung und therapie von knochenkrebs.
ATE170077T1 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
LV10441A (lv) Pirimidin-4,6-dikarbonskabes diamidi to iegusanas panemiens to pielietojums un arstniecibas lidzekli kas satur minetos savienojumus
DE69432418D1 (de) Phosphonate- und nicht-phosphonate einheiten enthaltende polyamino-paramagnetische-chelate fuer anwendung in mri
ES528703A0 (es) Procedimiento para preparar derivados de prolina disustituidos
FI895141A0 (fi) Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
DK0944389T3 (da) Oprensede sammensætninger af 10-propargyl-10-deazaaminopterin og fremgangsmåder til anvendelse deraf i behandlingen af tumorer
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
TR200103561T2 (tr) Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları
DK601888D0 (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
GB2004550A (en) Dibenzocycloocten-imines
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DK159769C (da) Resorcinderivater og analogifremgangsmaade til fremstilling heraf, farmaceutiske praeparater indeholdende disse, samt fremgangsmaade til fremstilling af disse farmaceutiske praeparater
RU92016532A (ru) Бензохиназолиновые соединения, способ их получения, фармацевтическая композиция и способ лечения
ATE96035T1 (de) Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs.
DE59003806D1 (de) Zubereitung eines salzes von oxypurinol in oraler form zur behandlung von hyperuricämie.